| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 1,090 | 1,226 | 1,087 | 1,352 | | Cost of Revenue | 800 | 707 | 650 | 1,213 | | | Gross Profit | 290 | 519 | 437 | 139 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 513 | 532 | 741 | 1,677 | | Non Recurring |
-
|
-
|
-
|
-
| | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | (223) | (13) | (304) | (1,538) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 15 | 15 | 33 | 82 | | Earnings Before Interest And Taxes | (217) | 2 | (271) | (1,456) | | Interest Expense | (9) | 6 | 3 | 4 | | Income Before Tax | (208) | (4) | (274) | (1,460) | | Income Tax Expense |
-
|
-
|
-
|
-
| | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | (208) | (4) | (274) | (1,460) | | | Non-recurring Events | | Discontinued Operations | 10 | (2) | (12) | (91) | | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (198) | (6) | (286) | (1,551) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($198) | ($6) | ($286) | ($1,551) |
|
0.45% Nasdaq 
Income Statement
